| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 92,328 | 62,433 | 56,499 | 99,674 | | Cost of Revenue | 47,827 | 38,311 | 34,958 | 55,609 | | | Gross Profit | 44,501 | 24,122 | 21,541 | 44,065 | | | Operating Expenses | | Research Development | 17,258 | 14,285 | 18,443 | 25,192 | | Selling General and Administrative | 11,839 | 10,377 | 11,207 | 15,094 | | Non Recurring |
-
|
-
| 8,407 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,404 | (540) | (16,516) | 3,779 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | 873 | (1,330) | 703 | | Earnings Before Interest And Taxes | 15,425 | 333 | (17,846) | 4,482 | | Interest Expense | 68 | 90 | 763 | 1,789 | | Income Before Tax | 15,357 | 243 | (18,609) | 2,693 | | Income Tax Expense | 5,429 | 452 | (6,513) | (63) | | Minority Interest | 2,200 |
-
|
-
| 824 | | | | Net Income From Continuing Ops | 12,128 | (209) | (12,096) | 3,580 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,128 | (209) | (12,096) | 3,580 | | Preferred Stock And Other Adjustments | (1,343) | 734 | 609 |
-
| | | Net Income Applicable To Common Shares | $10,785 | $525 | ($11,487) | $3,580 |
|
0.02% Nasdaq 
Income Statement
